Advancing Innovation Through Strategic Readiness
At Rezk Ventures, we partner with innovators, visionaries, and trailblazers in the biotech space to drive impactful solutions for emerging markets. To ensure the success of every collaboration, we evaluate potential partners based on their readiness to deliver results, scale innovation, and create sustainable value.
Our proprietary Investment Readiness Evaluation Framework (IREF) categorizes organizations into Gold, Silver, and Bronze tiers, ensuring tailored support and guidance at every stage of readiness.
The Investment Readiness Evaluation Framework (IREF)
How It Works:
The IREF assesses key aspects of your project or organization, including your product pipeline, clinical and regulatory progress, operational capacity, and market potential. Each tier represents a level of readiness and qualifies you for specific types of support and investment.
Why IREF Matters
- Structured Success: Aligns readiness levels with tailored investments to maximize impact.
- Scalable Growth: Helps organizations progress through stages with targeted support.
- Aligned Vision: Ensures all partners are mission-driven and capable of delivering transformative healthcare solutions.
IREF Criteria
Clinical Trial Phase (post Phase I):
Focus on assets that have advanced beyond early safety testing to ensure higher success potential
Robustness of Clinical Trial Data (Efficacy and Safety):
Demonstrates the asset’s ability to meet regulatory and therapeutic standards
Organizational Structure and Team Expertise:
Strong leadership and specialized teams ensure efficient operations and scalability
Manufacturing Capacity and Scalability:
Evaluates readiness to meet clinical and commercial production demands.
Drug Substance (DS) and Drug Product (DP) Status (Clinical or Commercial):
Tracks the progress of DS and DP through clinical or commercial readiness stages
Registration Timelines in the Country of Origin:
Measures efficiency in achieving regulatory approvals in domestic markets.
Previous GMP Inspections and Certifications (e.g., PICS, SRA):
Validates compliance with global quality manufacturing standards.
International Market Registrations Achieved:
Demonstrates the asset’s potential for global scalability and adoption.
Number of Pipeline Products and Their Development Phases:
Reflects innovation and long-term value through a diverse and progressing pipeline.
Market Potential Analysis and Demand Forecasting:
Ensures the asset addresses significant unmet needs with strong market demand.
Revenue or External Funding History:
Indicates financial health and ability to attract investments.
Intellectual Property (IP) Protection and Patent Portfolio:
Secures competitive advantage and protects innovation.
Biotech Tiers
Gold
Silver
Silver
- Market-Ready Products: At least 10+ products in Phase III or later stages
- Regulatory Excellence: Proven track record of passing international GMP inspections (e.g., PICS, SRA) and achieving registrations in multiple global markets.
- Scalable Operations: Fully operational GMP-compliant manufacturing capacity capable of meeting commercial demand.
Silver
Silver
Silver
- Promising Pipeline: At least 5 product in late Phase II or early Phase III with preliminary efficacy and safety data.
- Regulatory Progress: Dossier readiness or active registration efforts in the country of origin and initial international markets.
- Emerging Infrastructure: GMP-compliant facilities for clinical-scale production with plans to scale for commercialization.
Bronze
Silver
Bronze
- Early Development: At least 2 product in Phase II or progressing from Phase I with safety data available.
- Regulatory Foundation: Limited registration progress but committed to meeting regulatory standards.
- Basic Operations: Outsourced or minimal in-house manufacturing capabilities with scalability potential.
Are You Investment Ready?
Partner With Rezk Ventures to Advance Biotech Innovation
Let’s shape the future of healthcare through strategic investments in clinical trials, licensing, and technology transfer
Rezk Ventures
Dubai Science Park - Dubai - United Arab Emirates
South Tower - office 187 and 188 Email : partnerships@rezkfoundation.com
